Market Tracker

04/21 5:16pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.6644
Delayed Data
As of Apr 21
 -0.0225 / -3.28%
Today’s Change
0.60
Today|||52-Week Range
3.27
-7.04%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.69
Today’s open0.69
Day’s range0.65 - 0.69
Volume284,213
Average volume (3 months)1,102,864
Market cap$14.6M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+21.90%
Earnings growth (this year)+1.22%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.12%
P/E ratioNM
Price/Sales253.76
Price/Book1.18

Competitors

 Today’s
change
Today’s
% change
PZRXPhaseRx Inc-0.01-0.80%
CBMXCombiMatrix Corp+0.10+2.13%
TENXTenax Therapeutics I...-0.00-0.86%
IGCIndia Globalization ...+0.06+13.02%
Data as of 4:02pm ET, 04/21/2017

Financials

Next reporting dateMay 18, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$19.0K
Annual profit (last year)-$9.0M
Net profit margin-47,336.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts